Sanofi announces it will work with HHS to develop coronavirus vaccine
Sanofi said it expects to have a coronavirus vaccine candidate — a prototype — to test in vitro within six months and could be ready to test the vaccine in…
by Helen Branswell
Feb 18, 2020
3 minutes
The drug maker Sanofi Pasteur is entering the race to develop a vaccine to protect against the new coronavirus sweeping through China, the company announced Monday.
David Loew, Sanofi’s global head of vaccines, said the company would partner with the U.S. Biomedical Advanced Research and Development Authority — known as BARDA — to make a vaccine using the company’s recombinant DNA platform.
Loew said the company’s previous work to develop a vaccine for SARS — a cousin virus — gives it a leg up on this work.
You’re reading a preview, subscribe to read more.
Start your free 30 days